v3.26.1
STOCKHOLDERS EQUITY (DEFICIT) (Details 2) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Dec. 31, 2024
STOCKHOLDERS EQUITY (DEFICIT)      
Number of warrants outstanding, beginning 5,640,000 2,270,000 1,000,000
Number of warrants granted 350,000 3,370,000 1,270,000
Number of warrants outstanding, ending 5,990,000 5,640,000 2,270,000
Number of warrants vested and exercisable, ending 5,990,000 5,640,000 2,270,000
Weighted average exercise price outstanding, beginning $ 2.45 $ 3.50 $ 3.50
Weighted average exercise price granted 0.01 1.75 3.50
Weighted average exercise price outstanding, ending 2.45 2.45 3.50
Weighted average exercise price vested and exercisable, ending $ 2.45 $ 2.45 $ 3.50
Weighted average remaining contractual term (years) outstanding, beginning 3 years 3 months 18 days 2 years 1 month 6 days 1 year 7 months 6 days
Weighted average remaining contractual term, granted   5 years 1 month 6 days 2 years 2 months 12 days
Weighted average remaining contractual term (years) outstanding, ending 3 years 3 months 18 days 3 years 3 months 18 days 1 year 7 months 6 days
Weighted average remaining contractual term (years) vested and exercisable, ending 3 years 3 months 18 days 3 years 2 years 1 month 6 days
Aggregate intrinsic value outstanding, beginning $ 20,954,615 $ 3,382,300 $ 2,500,000
Aggregate intrinsic value outstanding, ending 23,361,000 20,954,615 3,382,300
Aggregate intrinsic value vestd and exercisbale, ending $ 23,361,000 $ 20,954,615 $ 3,382,300